Jean-Baptiste Alberge1 article listing Jean-Baptiste Alberge in Nature Communications, indexed by Paperzzz from Crossref and OSF.Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study Nature Communications